Ray Dalio
BIO icon

Ray Dalio’s Bio-Rad Laboratories Class A BIO Stock Holding History

Ray Dalio’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$469K Buy
+1,684
New +$485K ﹤0.01% 894
2025
Q4 		– Sell
-10,632
Closed -$2.98M – 1064
2025
Q3 		$2.98M Buy
+10,632
New +$2.89M 0.01% 623
2024
Q1 		– Sell
-771
Closed -$249K – 701
2023
Q4 		$249K Sell
771
-15,988
-95% -$5.01M ﹤0.01% 736
2023
Q3 		$6.01M Buy
16,759
+290
+2% +$112K 0.04% 326
2023
Q2 		$6.24M Buy
16,469
+15,666
+1,951% +$6.38M 0.04% 263
2023
Q1 		$385K Sell
803
-11,171
-93% -$5.23M ﹤0.01% 667
2022
Q4 		$5.03M Buy
11,974
+3,563
+42% +$1.44M 0.03% 358
2022
Q3 		$3.51M Buy
8,411
+5,178
+160% +$2.58M 0.02% 454
2022
Q2 		$1.6M Buy
3,233
+2,848
+740% +$1.48M 0.01% 723
2022
Q1 		$217K Buy
+385
New +$232K ﹤0.01% 958
2019
Q1 		– Sell
-6,590
Closed -$1.53M – 335
2018
Q4 		$1.53M Buy
6,590
+4,574
+227% +$1.23M 0.01% 281
2018
Q3 		$631K Buy
2,016
+184
+10% +$57.1K 0.01% 262
2018
Q2 		$529K Sell
1,832
-1,777
-49% -$491K 0.01% 358
2018
Q1 		$903K Sell
3,609
-15,646
-81% -$3.98M 0.01% 282
2017
Q4 		$4.6M Buy
+19,255
New +$4.67M 0.04% 91
2015
Q4 		– Sell
-2,978
Closed -$400K – 290
2015
Q3 		$400K Buy
+2,978
New +$429K 0.01% 367

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ray Dalio's BIO Position: Q1 2026 in Review

Ray Dalio opened a new position in Bio-Rad Laboratories Class A (BIO) in Q1 2026: 1,684 shares worth $469K. The stake represents ﹤0.01% of the portfolio and ranks #894 among its holdings. This is a return to the name: Ray Dalio previously reported a position in BIO as recently as Q3 2025.

Ray Dalio first reported a position in BIO in Q3 2015 and has held it in 16 quarters since. The position peaked at $6.24M in Q2 2023. 393 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Ray Dalio held 1,684 shares of Bio-Rad Laboratories Class A worth $469K as of Q1 2026.
  • Bio-Rad Laboratories Class A was a new Ray Dalio position in Q1 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Ray Dalio's portfolio in Q1 2026, its #894 holding.
  • Ray Dalio first reported a position in Bio-Rad Laboratories Class A in Q3 2015 and has held it in 16 quarters since.
  • Ray Dalio's Bio-Rad Laboratories Class A position peaked at $6.24M in Q2 2023.
  • 393 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.